Ling Gabriel bought TOI

November 18, 2025 · Form 4 insider transaction

Ling Gabriel bought 141,149 shares of Starling Oncology Inc, a transaction worth N/A. The trade was recorded as j and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Acquired (buy-side)
Shares
141,149
Price
N/A
Total value
N/A
Role
SecurityCommon Stock
Transaction codeJ: J
Transaction dateNovember 18, 2025
Filing dateNovember 20, 2025
Shares owned after250,206
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

Consists of shares of common stock of the Issuer received by the reporting person through an in-kind distribution by M33 Growth I, L.P. to its limited partners and on a pro rata basis in accordance with their pecuniary interests therein in reliance on Rules 16a-9 and 16a-13 under the Securities Exchange Act of 1934, as amended.

View the original Form 4 on SEC EDGAR